510(k) K192028— Yumizen C1200 CRP

Substantially Equivalent

HORIBA ABX SAS

Clearance details

Applicant: HORIBA ABX SAS
Product code: Code DCK
Advisory panel: Immunology
Date received: 2019-07-26
Decision date: 2020-06-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Montpellier Cedex 4, FR

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.